Dermapharm Holding SE
DUS:DMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dermapharm Holding SE
DUS:DMP
|
DE |
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
Moncler SpA
OTC:MONRF
|
IT |
|
Land Securities Group PLC
LSE:LAND
|
UK |
|
Threat Protect Australia Ltd
ASX:TPS
|
AU |
|
Moncler SpA
OTC:MONRY
|
IT |
|
Q
|
Qiagen NV
XMUN:QIA
|
NL |
|
G
|
Grenke AG
DUS:GLJ
|
DE |
|
Brera Holdings PLC
NASDAQ:SLMT
|
IE |
|
A
|
Amgen Inc
XMUN:AMG
|
US |
|
NetraMark Holdings Inc
F:PF0
|
CA |
|
Minerva SA
F:M0V
|
BR |
|
M
|
Match Group Inc
F:4MGN
|
US |
Bankruptcy Probability
Dermapharm Holding SE's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Dermapharm Holding SE Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Dermapharm Holding SE
XETRA:DMP
|
2.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
642.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
325.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
246.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
200.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
207.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Dermapharm Holding SE's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Dermapharm Holding SE has total debt of 916.3m EUR. This includes both short-term (0 EUR) and long-term (916.3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
